The purpose of this study was to examine the effects of continuous lapatinib exposure on the growth of HER2-positive breast cancer cells in order to examine possible mechanisms of lapatinib action and to elucidate potential mechanisms for the development of acquired resistance. This evidence concerns the gene ERBB2 and breast carcinoma.